Biomedica |大內皮素-1是LVNC患者的預後指標

Biomedica |大內皮素-1是LVNC患者的預後指標

2021.03.08

本文轉載自原廠電子報:Biomedica | www.bmgrp.com | 電子報原文

Big Endothelin-1 (Big ET-1) is a protein that is mainly produced by vascular endothelial and smooth muscle cells and cardiomyocytes. Big ET-1 has been identified as a risk factor for a poor prognosis in patients with atrial fibrillation or coronary artery disease. This current study revealed that plasma Big ET-1 is a valuable tool for risk stratification in patients with LVNC.

 

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.

 Fan P et al., 2020. Heart. 2020 Oct 14:heartjnl-2020-317059.

For product information click here.

Did you know? 

 

Big ET-1 can easily be measured using Biomedica’s ELISA:

 

√ Direct measurement – highly sensitive

√ CE-marked  for IVD use in the EU

 Fully validated according to FDA/ICH/EMEA guidelines

 Published cut-off values

Your Biomedica Immunoassays Team

back-Top
open-line

LINE 線上諮詢

亞旭-LINE-QRcode

掃瞄或手機直接點擊條碼

error: Content is protected !!